Q2 2026 Portfolio in Review
Somehow, we’re already halfway through 2026 — and it’s been a busy quarter. Q2 brought a steady stream of exciting updates from across the portfolio, including major milestones, new launches, fundraising wins, and a few viral moments. We’re happy to share a handful of highlights from the quarter, knowing this is just a snapshot of […]
We’re Bio-Bullish
For over a decade, we’ve been spending time in health and bio. It’s a category we’ve been watching closely. In the early days, we wrote a lot about the space – from healthcare marketplaces to the role of genomics in personalized medicine. And we made a handful of investments in tools and diagnostics like: Gencove […]
Announcing our investment in GridBank
Today, we’re excited to announce that we’ve co-led the $6M seed round of GridBank, a company building the global transaction network for real-world data. At its core, GridBank turns every smartphone into a data node, enabling people to capture and sell real-world video, images, and location-tagged media to companies that need it. Pricing is dynamic […]
Q1 2026 Portfolio in Review
We’re a quarter of the way through 2026, and the V1 family is off to a fast start. Across the portfolio, teams are building with urgency, laying the groundwork for what we expect to be another strong year ahead. Before we get too far into Q2, we wanted to take a moment to share a […]
Q4 2025 portfolio recap (+ Happy New Year!)
Happy New Year! The final quarter of 2025 brought meaningful momentum across the V1 portfolio, with founders closing Q4 strong and building toward an even bigger 2026. We’re excited to carry that progress into the months ahead. Before we fully shift our focus to what’s next, here’s a look back at a few highlights and […]